William Ince
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 09, 2025
Correction to: Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.Ricky Frazer, José Ángel Arranz, Sergio Vázquez Estévez
|Nov 20, 2024
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.Ricky Frazer, José Ángel Arranz, Sergio Vázquez Estévez
|Jun 18, 2024
Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives.Elinor R Gatfield, John Tadross, William Ince
|Dec 07, 2021
Combination therapies in clinical trials for renal cell carcinoma: how could they impact future treatments?Will Ince, Tim Eisen
|Aug 11, 2021
What is the role of real-world data in metastatic renal cell cancer?Will Ince, Kate Fife
Pageof 1